3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(thiophen-2-yl)pyrazolo[1,5-a]pyrimidine

Catalog No. :
ACDRCK355
CAS No. :
2209037-35-2
Molecular Formula :
C16H18BN3O2S
Molecular Weight :
327.22

IUPAC Name:3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(thiophen-2-yl)pyrazolo[1,5-a]pyrimidine

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(thiophen-2-yl)pyrazolo[1,5-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(thiophen-2-yl)pyrazolo[1,5-a]pyrimidine
IUPAC Name3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(thiophen-2-yl)pyrazolo[1,5-a]pyrimidine
Molecular FormulaC16H18BN3O2S
Molecular Weight327.22
SMILESCC1(C)C(C)(C)OB(C2=C3N=C(C4=CC=CS4)C=CN3N=C2)O1
InChI KeyGUNAPCKFWCGWBX-UHFFFAOYSA-N
SynonymPyrazolo[1,5-a]pyrimidine, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(2-thienyl)-
CAS No.2209037-35-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACDRCK355 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACDRCK355 route product structure diagram
    ACDRCK3552209037-35-2
Inquiry

2. ACDRCK355 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDRCK355 route product structure diagram
    ACDRCK3552209037-35-2
Inquiry

Comments (0)